Cell lines with resistance to MDM2/p53 binding antagonists were generated by continuously exposing SJSA-1 osteosarcoma cells and NGP neuroblastoma cells to either Nutlin-3 or MI-63. The gene discussed is MDM2; the disease is osteosarcoma.